[1] |
BOLOGNESI M, MERKEL C, SACERDOTI D, et al. Role of spleen enlargement in cirrhosis with portal hypertension[J]. Dig Liver Dis, 2002, 34(2): 144-150. DOI: 10.1016/s1590-8658(02)80246-8.
|
[2] |
MCCORMICK PA, MURPHY KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease[J]. Baillieres Best Pract Res Clin Gastroenterol, 2000, 14(6): 1009-1031. DOI: 10.1053/bega.2000.0144.
|
[3] |
ISHIGAMI M, ISHIZU Y, ONISHI Y, et al. Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology[J]. Springerplus, 2013, 2: 374. DOI: 10.1186/2193-1801-2-374.
|
[4] |
ORLANDO R, LIRUSSI F, BASSO SM, et al. Splenomegaly as risk factor of liver cirrhosis. A retrospective cohort study of 2, 525 patients who underwent laparoscopy[J]. In Vivo, 2011, 25(6): 1009-1012.
|
[5] |
XU JH, FAN YN, JI TT, et al. Clinical characteristics of 500 hospitalized patients with liver cirrhosis: a retrospective analysis from a tertiary hospital in Beijing[J]. Chin J Hepatol, 2022, 30(5): 541-545. DOI: 10.3760/cma.j.cn501113-20201126-00631.
|
[6] |
HUANG X, YAO L, DENG ZR, et al. Analysis of clinical characteristics of 481 HBV-related liver cirrhotic patients with low viral load[J]. Chin J Hepatol, 2021, 29(3): 227-233. DOI: 10.3760/cma.j.cn501113-20200302-00081.
|
[7] |
YAMADA S, MORINE Y, IMURA S, et al. Liver regeneration after splenectomy in patients with liver cirrhosis[J]. Hepatol Res, 2016, 46(5): 443-449. DOI: 10.1111/hepr.12573.
|
[8] |
WANG Y. The mechanism of splenectomy for improving liver function in patients with liver cirrhosis[D]. Wuhan: Wuhan University, 2019.
王银. 肝硬化患者脾脏切除术改善肝脏功能的机制研究[D]. 武汉: 武汉大学, 2019.
|
[9] |
SHEN DF, GU XH, QI DJ, et al. Effect of splenic artery ligation on liver regeneration in rats following partial hepatectomy by measuring hepatocyte growth factor and transforming growth factor-β1[J]. J Exp Surg, 2019, 36(3): 455-457. DOI: 10.3760/cma.j.issn.1001-9030.2019.03.018.
|
[10] |
MATSUO R, OHKOHCHI N, MURATA S, et al. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro[J]. J Surg Res, 2008, 145(2): 279-286. DOI: 10.1016/j.jss.2007.02.035.
|
[11] |
ELCHANINOV AV, FATKHUDINOV TK, VISHNYAKOVA PA, et al. Molecular mechanisms of splenectomy-induced hepatocyte proliferation[J]. PLoS One, 2020, 15(6): e0233767. DOI: 10.1371/journal.pone.0233767.
|
[12] |
KAWANAKA H, AKAHOSHI T, KINJO N, et al. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension[J]. Br J Surg, 2014, 101(12): 1585-1593. DOI: 10.1002/bjs.9622.
|
[13] |
KONG DG, LU SC, WU JS, et al. A clinical study of the combined effects of splenectomy on the cirrhotic liver[J]. J Hepatobiliary Surg, 2022, 28(7): 499-503. DOI: 10.3760/cma.j.cn113884-20210402-00123.
|
[14] |
LIU GW, WU X, TANG D, et al. Re-observation of splenectomy and esophagogastric devascularization in patients with hepatitis B cirrhosis and portal hypertension[J]. J Hepatol, 2021, 24(5): 649-652. DOI: 10.3969/j.issn.1672-5069.2021.05.011.
|
[15] |
ZENG DB, DI L, GUO QL, et al. Splenectomy with portoazygous disconnection for correction of systemic hemodynamic disorders in hepatic cirrhosis patients with portal hypertension: a prospective single-center cohort study[J]. Can J Gastroenterol Hepatol, 2020, 2020: 8893119. DOI: 10.1155/2020/8893119.
|
[16] |
IWAKIRI Y. Endothelial dysfunction in the regulation of cirrhosis and portal hypertension[J]. Liver Int, 2012, 32(2): 199-213. DOI: 10.1111/j.1478-3231.2011.02579.x.
|
[17] |
ANGUS PW. Role of endothelin in systemic and portal resistance in cirrhosis[J]. Gut, 2006, 55(9): 1230-1232. DOI: 10.1136/gut.2005.088633.
|
[18] |
EIPEL C, ABSHAGEN K, VOLLMAR B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited[J]. World J Gastroenterol, 2010, 16(48): 6046-6057. DOI: 10.3748/wjg.v16.i48.6046.
|
[19] |
LI YD, ZHANG HX, ZHAO YB, et al. Changes in cardiac hemodynamic parameters after splenectomy for peripancreatic vessel dissection in patients with cirrhotic portal hypertension[J]. Chin J Hepat, 2019, 24(6): 669-671. DOI: 10.14000/j.cnki.issn.1008-1704.2019.06.028.
|
[20] |
|
[21] |
MA JL, HE LL, LI P, et al. Prognosis of endotherapy versus splenectomy and devascularization for variceal bleeding in patients with hepatitis B-related cirrhosis[J]. Surg Endosc, 2021, 35(6): 2620-2628. DOI: 10.1007/s00464-020-07682-6.
|
[22] |
QI RZ, ZHAO X, WANG SZ, et al. Analysis of postoperative complications and survival in 1, 118 cases of open splenectomy with flow dissection for portal hypertension[J]. Chin J Surg, 2018, 56(6): 436-441. DOI: 10.3760/cma.j.issn.0529-5815.2018.06.010.
|
[23] |
DUAH A, NKRUMAH KN, TACHI K. Non-invasive markers as predictors of oesophageal varices in cirrhotic patient in a teaching hospital in Ghana[J]. Ghana Med J, 2019, 53(2): 142-149. DOI: 10.4314/gmj.v53i2.9.
|
[24] |
LI ZW, QI ZR, ZHAO X, et al. Development of incision minimally invasion of splenectomy for portal hypertension[J/CD]. Chin J Hepat Surg: Electronic Edition, 2022, 11(1): 17-20. DOI: 10.3877/cma.j.issn.2095-3232.2022.01.005
李志伟, 齐瑞兆, 赵新, 等. 门静脉高压症脾切除切口微创化发展[J/CD]. 中华肝脏外科手术学电子杂志, 2022, 11(1): 17-20. DOI: 10.3877/cma.j.issn.2095-3232.2022.01.005
|
[25] |
ZENG DB, DI L, ZHANG RC, et al. The effect of splenectomy on the reversal of cirrhosis: a prospective study[J]. Gastroenterol Res Pract, 2019, 2019: 5459427. DOI: 10.1155/2019/5459427.
|
[26] |
LIANG QS, XIE JG, YU C, et al. Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK/TGF-β1 signaling pathway[J]. Exp Mol Med, 2021, 53(3): 393-406. DOI: 10.1038/s12276-021-00574-2.
|
[27] |
LI N, WANG Z, LIN J. Up-regulated expression of PTEN after splenetomy may prevent the progression of liver fibrosis in rats[J]. J Hepatobiliary Pancreat Sci, 2016, 23(1): 50-56. DOI: 10.1002/jhbp.300.
|
[28] |
WATANABE M, MURATA S, HASHIMOTO I, et al. Platelets contribute to the reduction of liver fibrosis in mice[J]. J Gastroenterol Hepatol, 2009, 24(1): 78-89. DOI: 10.1111/j.1440-1746.2008.05497.x.
|
[29] |
HAYASHI H, BEPPU T, SHIRABE K, et al. Management of thrombocytopenia due to liver cirrhosis: a review[J]. World J Gastroenterol, 2014, 20(10): 2595-2605. DOI: 10.3748/wjg.v20.i10.2595.
|
[30] |
LV YF, LI XQ, GONG XG, et al. Effect of surgery treatment on hypersplenism caused by cirrhotic portal hypertension[J]. Minerva Chir, 2013, 68(4): 409-413. DOI: 10.1016/j.jpedsurg.2012.09.048.
|
[31] |
|
[32] |
JANDL JH, Aster RH. Increased splenic pooling and the pathogenesis of hypersplenism[J]. Am J Med Sci, 1967, 253(4): 383-398. DOI: 10.1097/00000441-196704000-00001.
|
[33] |
WANG YX, LI GW, LI ZF. The role of splenomegaly and splenic macrophage in the occurrence of hypersplenism of portal hypertension[J]. J Xi'an Med Univ, 2001(2): 129-131. DOI: 10.3969/j.issn.1671-8259.2001.02.011.
|
[34] |
|
[35] |
YOSHIDA D, NAGAO Y, TOMIKAWA M, et al. Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients[J]. Hepatol Int, 2012, 6(3): 657-661. DOI: 10.1007/s12072-011-9315-6.
|
[36] |
WANG P, LI Z, REN S, et al. Spleen regulates hematopoietic stem/progenitor cell functions through regulation of egf in cirrhotic hypersplenism[J]. Dig Dis Sci, 2018, 63(7): 1860-1867. DOI: 10.1007/s10620-018-5091-7.
|
[37] |
LV Y, WU H, LAU WY, et al. Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension[J]. Sci Rep, 2021, 11(1): 21246. DOI: 10.1038/s41598-021-00692-x.
|
[38] |
HUANG N, JI FP, ZHANG S, et al. Spleen-associated effects on immunity in hepatitis B virus-related cirrhosis with portal hypertension[J]. J Interferon Cytokine Res, 2019, 39(2): 95-105. DOI: 10.1089/jir.2018.0121.
|
[39] |
HIRAKAWA Y, OGATA T, SASADA T, et al. Immunological consequences following splenectomy in patients with liver cirrhosis[J]. Exp Ther Med, 2019, 18(1): 848-856. DOI: 10.3892/etm.2019.7640.
|
[40] |
LV X, YANG F, GUO X, et al. Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis[J]. Tumour Biol, 2016, 37(7): 8889-8900. DOI: 10.1007/s13277-015-4764-5.
|
[41] |
ZHANG XF, LIU Y, LI JH, et al. [Effect of splenectomy on the risk of hepatocellular carcinoma development among patients with liver cirrhosis and portal hypertension: a multi-institutional cohort study][J]. Chin J Surg, 2021, 59(10): 821-828. DOI: 10.3760/cma.j.cn112139-20210713-00308.
|
[42] |
HUANG N, JI F, ZHANG S, et al. Effect of splenectomy on serum cytokine profiles in hepatitis b virus-related cirrhosis patients with portal hypertension[J]. Viral Immunol, 2018, 31(5): 371-378. DOI: 10.1089/vim.2017.0176.
|
[43] |
ZENG DB, ZHANG C, DI L, et al. The impact of splenectomy and esophagogastric devascularization on the nutrition status of patients with cirrhosis and portal hypertension[J]. J Hepatobiliary Surg, 2017, 23(7): 437-440. DOI: 10.3760/cma.j.issn.1007-8118.2017.07.002.
|
[44] |
SINWAR PD. Overwhelming post splenectomy infection syndrome-review study[J]. Int J Surg, 2014, 12(12): 1314-1316. DOI: 10.1016/j.ijsu.2014.11.005.
|
[45] |
SHENG CF, LIU BY, ZHANG HM, et al. Overwhelming postsplenectomy infection[J]. Genet Mol Res, 2015, 14(1): 2702-2706. DOI: 10.4238/2015.March.30.30.
|
[46] |
WU Y, LI H, ZHANG T, et al. Splanchnic vein thrombosis in liver cirrhosis after splenectomy or splenic artery embolization: a systematic review and meta-analysis[J]. Adv Ther, 2021, 38(4): 1904-1930. DOI: 10.1007/s12325-021-01652-7.
|
[47] |
QI X, HAN G, YE C, et al. Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J]. Med Sci Monit, 2016, 22: 2528-2550. DOI: 10.12659/msm.898866.
|
[48] |
JIANG S, AI Y, NI L, et al. Platelet-derived TGF-β1 is related to portal vein thrombosis in cirrhosis by promoting hypercoagulability and endothelial dysfunction[J]. Front Cardiovasc Med, 2022, 9: 938397. DOI: 10.3389/fcvm.2022.938397.
|
[49] |
|
[50] |
WANG H, SHEN XX, CHEN LQ, et al. Association of JAK/STAT signaling pathway with portal vein thrombosis after splenectomy in cirrhotic patients with portal hypertension[J]. J Clin Hepatol, 2022, 38(10): 2260-2264. DOI: 10.3969/j.issn.1001-5256.2022.10.012.
|